Aaron J. Schetter

National Institutes of Health — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

49h-index11.5kcitations228works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related molecular mechanisms research(88), MicroRNA in disease regulation(82), Circular RNAs in diseases(55), RNA modifications and cancer(53), Lung Cancer Treatments and Mutations(26)

Publications227 total

Data from A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma
2023Open Access
Supplementary Tables S1, S2 from Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer
2023Open Access
Supplemental Table 3 from The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts
2023Open Access
Supplementary Data from MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
2023Open Access
Supplemental Figure S3 from A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma
2023Open Access
Supplementary Table S2. Safety Population - Common ({greater than or equal to} 10%) Adverse Reactions from FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
2023Open Access
Supplementary Table S4-S7 from Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer
2023Open Access
Data from Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer
2023Open Access
Data from FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
2023Open Access
Supplementary Figures 1 - 5 from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Supplementary Table S1. Use of Grouped Termsa for Summary Tabulations of Adverse Reactions from FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
2023Open Access
Supplementary Figure 2 from The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal Mucosa
2023Open Access
Supplementary Table S4-S7 from Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer
2023Open Access
Supplementary Figure S1. Study 20120148 - Hematological relapse-free survival for patients in CR1 by MRD level at baseline after at least 3 intensive chemotherapy blocks from FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
2023Open Access
Data from Inflammatory and MicroRNA Gene Expression as Prognostic Classifier of Barrett's-Associated Esophageal Adenocarcinoma
2023Open Access
Supplementary Data from The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts
2023Open Access
Supplementary Materials and Methods from Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer
2023Open Access
Supplemental Figure S1 from A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma
2023Open Access
Data from MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
2023Open Access
Supplemental Figure 1 from The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Curtis C. Harris(34), Elise D. Bowman(14), Hirokazu Okayama(8), Ewy A. Mathé(8), Ana I. Robles(8), Carlo M. Croce(7), S. Perwez Hussain(7), Giang Huong Nguyen(7), Jochen Gaedcke(6), Thomas Ried(6), Takashi Kohno(5), Jun Yokota(5), Peijun He(5), Nader Hanna(5), H. Richard Alexander(5), Harris G. Yfantis(5), Fabio Piano(5), Stefan Ambs(5), Jane J. Sohn(4), Aage Haugen(4)